| 1 | LLY | Eli Lilly and Company | 10.23% |
| 2 | UNH | UnitedHealth Group Incorporated | 4.41% |
| 3 | RHHBY | Roche Holding AG | 4.38% |
| 4 | LON: AZN | AstraZeneca PLC | 4.28% |
| 5 | ABT | Abbott Laboratories | 3.92% |
| 6 | GILD | Gilead Sciences, Inc. | 3.77% |
| 7 | TMO | Thermo Fisher Scientific Inc. | 3.70% |
| 8 | BSX | Boston Scientific Corporation | 3.51% |
| 9 | ABBV | AbbVie Inc. | 3.12% |
| 10 | JNJ | Johnson & Johnson | 3.02% |
| 11 | SWX: NOVN | Novartis AG | 2.94% |
| 12 | MDT | Medtronic plc | 2.92% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.71% |
| 14 | DHR | Danaher Corporation | 2.64% |
| 15 | MRK | Merck & Co., Inc. | 2.34% |
| 16 | CPH: NOVO.B | Novo Nordisk A/S | 2.25% |
| 17 | REGN | Regeneron Pharmaceuticals, Inc. | 2.18% |
| 18 | AMGN | Amgen Inc. | 2.15% |
| 19 | BBIO | BridgeBio Pharma, Inc. | 2.02% |
| 20 | ARWR | Arrowhead Pharmaceuticals, Inc. | 1.97% |
| 21 | CYTK | Cytokinetics, Incorporated | 1.95% |
| 22 | MCK | McKesson Corporation | 1.94% |
| 23 | RVMD | Revolution Medicines, Inc. | 1.82% |
| 24 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.81% |
| 25 | BMY | Bristol-Myers Squibb Company | 1.79% |
| View HRTS holdings |
